| Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559) |
|---|
| 07/26/2006 | EP1682546A1 Peptidomimetic compounds, stereoselective process for their preparation, their use as biologically active synthetic intermediates |
| 07/26/2006 | EP1682545A1 Imidazopyridine substituted tropane derivatives with ccr5 receptor antagonist activity for the treatment of hiv and inflammation |
| 07/26/2006 | EP1682544A2 Hydroxylamine substituted imidazo ring compounds |
| 07/26/2006 | EP1682521A1 Macrocyclic lactams and pharmaceutical use thereof |
| 07/26/2006 | EP1682519A1 Pyridazin-3(2h)-one derivatives and their use as pde4 inhibitors |
| 07/26/2006 | EP1682510A2 Methods and compositions for selectin inhibition |
| 07/26/2006 | EP1682504A2 Hydroxy piperidine derivatives to treat gaucher disease |
| 07/26/2006 | EP1682500A1 Process for the preparation of ccr-2 antagonist |
| 07/26/2006 | EP1682138A2 Heterocyclic inhibitors of mek and methods of use thereof |
| 07/26/2006 | EP1682136A1 Therapeutic compounds and uses thereof |
| 07/26/2006 | EP1682135A1 Ccr-2 antagonist salt |
| 07/26/2006 | EP1682134A2 Glucoimidazole and polyhydroxycyclohexenyl amine derivatives to treat gaucher disease |
| 07/26/2006 | EP1601672B1 Triazolo-pyridines as anti-inflammatory compounds |
| 07/26/2006 | EP1549649B1 Process for preparing haloalkyl pyrimidines |
| 07/26/2006 | CN1809572A Substituted quinobenzoxazine analogs |
| 07/26/2006 | CN1809568A Pyrid (2, 1-a) - isoquinoline derivatives as dpp-iv inhibitors |
| 07/26/2006 | CN1809567A Novel imidazopyridine compound ii with therapeutic effect |
| 07/26/2006 | CN1809566A Cannabinoid receptor ligands and uses thereof |
| 07/26/2006 | CN1809565A Pyrrolodihydroisoquinolines as pde10 inhibitors |
| 07/26/2006 | CN1809564A Pyrrolodihydroisoquinolines as PDE10 inhibitors |
| 07/26/2006 | CN1809563A Pyridino[1,2-a]pyrimidin-4-one compounds as anticancer agents |
| 07/26/2006 | CN1809560A Thiazolylpiperidine derivatives as mtp inhibitors |
| 07/26/2006 | CN1809357A Small molecule Toll-like receptor (TLR) antagonists |
| 07/26/2006 | CN1809351A Inhibitors of Akt activity |
| 07/26/2006 | CN1266151C Naphthyridine derivatives |
| 07/26/2006 | CN1266150C 1, 2-dihydro-2-oxo-1, 8-naphthyridine derivative |
| 07/26/2006 | CN1266138C Gyrase imhibitors and uses thereof |
| 07/26/2006 | CN1266134C Fused-polycyclic compounds |
| 07/26/2006 | CN1266112C Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds |
| 07/25/2006 | US7081531 Bridged bicyclic amine derivatives useful as CCR-3 receptor antagonists |
| 07/25/2006 | US7081471 (-)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane, compositions thereof, and uses as a dopamine-reuptake inhibitor |
| 07/25/2006 | US7081466 anticarcinogenic agents with improved efficacy against multidrug resistant tumors; improved oral bioavailability and side effect reduction |
| 07/25/2006 | US7081463 Hydroxy alkyl substituted 1,3,8-Triazaspiro[4.5]decan-4-one derivatives useful for the treatment of orl-1receptor mediated disorders |
| 07/25/2006 | US7081462 Imidazo-substituted compounds as p38 kinase inhibitors |
| 07/25/2006 | US7081458 Small molecule, non-peptide antagonists; antidiabetic agents; obesity; {5-[1-4-Methoxy-2,3-dimethyl-phenyl)-ethyl]-(1S,4S)-2,5-diaza-bicyclo[2.2.1]hept-2-yl}-(4-trifluoromethyl-phenyl)-methanone |
| 07/25/2006 | US7081456 N-substitued-4-(3-oxo(thio)chromeno[4,3-c]pyrazol-2(3H)-yl) benzamides or N-substituted-4-(3-oxo-3,5-dihydro-pyrazolo[4,3-c]quinolin-2-yl) benzamides; CD80 antigen antagonists capable of inhibiting the interactions between CD80 and CD28 |
| 07/25/2006 | US7081455 sleep disorders associated with 5-HT2A serotonin receptor modulation; antagonists or agonists |
| 07/25/2006 | US7081449 Induce apoptosis; anticancer agents |
| 07/25/2006 | CA2168921C 1,6-naphthyridonecarboxylic acid derivatives |
| 07/20/2006 | WO2006076726A1 Synthesis of sodium narcistatin and related compounds |
| 07/20/2006 | WO2006076598A2 Bicyclic heterocycles as cannabinoid receptor modulators |
| 07/20/2006 | WO2006076597A1 Bicyclic heterocycles as cannabinoid receptor modulators |
| 07/20/2006 | WO2006075748A1 Therapeutic agent for allergic conjunctival disease |
| 07/20/2006 | WO2006075638A1 Novel heteroaryl derivative |
| 07/20/2006 | WO2006075094A2 Purine derivatives compositions containing the same and use thereof against cancer |
| 07/20/2006 | WO2006065280A3 Isoxazole, dihydroisoxazole, and oxadiazole substituted imidazo ring compounds and methods |
| 07/20/2006 | WO2006060678A3 Novel processes for the preparation of cgrp-receptor antagonists and intermediates thereof |
| 07/20/2006 | WO2006059210A3 Fused bicyclic pyrrols as hmg-coa reductase inhibitors |
| 07/20/2006 | WO2006026532A3 Methods of treatment of amyloidosis using substituted ethanolcyclicamine aspartyl protease inhibitors |
| 07/20/2006 | WO2005121130A3 Chemical compounds and pharmaceutical compositions containing them for the treatment of inflammatory disorders |
| 07/20/2006 | US20060160886 Chemical compounds |
| 07/20/2006 | US20060160885 Chemical compounds |
| 07/20/2006 | US20060160882 Indoline derivatives |
| 07/20/2006 | US20060160842 in brain; (2,5-difluorodifluorophenyl)-N-methyl-N-((1-propylbenzimidazol-2-yl)methyl)carboxamide; anxiolitic and antidepressant; finding and altering the signal-transducing activity of gamma aminobutyric acid (GABA) receptors; detectably-labeled antagonist/agonist of GABAR |
| 07/20/2006 | US20060160841 Crystallization via high-shear transformation |
| 07/20/2006 | US20060160839 2-[2-(4-methoxypyridin-2-yl)ethyl]-3H-imidazo[4,5-b]quinoline; inducible nitric oxide synthase inhibitor; antiinflammatory agent; acute and chronic inflammatory diseases of peripheral organs and CNS: sepsis, grafting, rheumatoid arthritis, eczema, diabetes, Alzheimer's, Parkinson's, and Crohn's diseases |
| 07/20/2006 | US20060160832 Nitrogen-containing aromatic derivatives |
| 07/20/2006 | US20060160827 Indolo[2,1-b] quinazole-6,12-dione antimalarial compounds and methods of treating malaria therewith |
| 07/20/2006 | US20060160811 Aryl-condensed 3-arylpridine compounds and use thereof for controlling pathogenic fungi |
| 07/20/2006 | US20060160805 Thiotungstate analogues and uses thereof |
| 07/20/2006 | US20060160798 3-Cyclohexyl-1-methyl-2-pyridin-2-yl-1H-indole-6-carboxylic acid methyl ester; hepatitis C virus infection; synergistic with another inhibitor of HCV polymerase or immunomodulatory agent such as interferons |
| 07/20/2006 | US20060160770 Method for the synthesis of 3-substituted indolizine and benzoindolizine compounds |
| 07/20/2006 | US20060159956 Fluorene-based derivative and organic electroluminescence device employing the same |
| 07/20/2006 | CA2595075A1 Pyrrolodihydroisoquinolines as antiproliferative agents |
| 07/20/2006 | CA2594569A1 Synthesis of sodium narcistatin and related compounds |
| 07/20/2006 | CA2593482A1 Heteroaryl substituted quinolin-4-ylamine analogues |
| 07/19/2006 | EP1681290A2 Imidazole derivatives, production method thereof and use thereof |
| 07/19/2006 | EP1680479A1 New organic compound and organic light emitting device using the same |
| 07/19/2006 | EP1680426A1 1.3.4-triaza-phenalene and 1,3,4,6-tetraazaphenalene derivatives |
| 07/19/2006 | EP1680424A2 Heteroaryl fused pyridines, pyrazines and pyrimidines as crf1 receptor ligands |
| 07/19/2006 | EP1680423A1 Azabenzodiazepines as phosphodiesterase-4 inhibitors |
| 07/19/2006 | EP1680422A1 Bispidon-derivated ligands and complex for catalytically bleaching a substrate |
| 07/19/2006 | EP1680421A2 Use of tricyclic compounds as glycine transport inhibitors |
| 07/19/2006 | EP1680420A2 Compounds, compositions, and methods |
| 07/19/2006 | EP1680415A1 Pyrrolidinyl urea derivatives as angiogenesis inhibitors |
| 07/19/2006 | EP1680406A1 N-substituted benzene sulfonamides |
| 07/19/2006 | EP1506194B1 SUBSTITUTED RING-FUSED IMIDAZOLE DERIVATES: GABA sb A /sb RECEPTOR LIGANDS |
| 07/19/2006 | EP1370556B1 Metalloproteinase inhibitors |
| 07/19/2006 | EP1294721B1 Cyclic gmp-specific phosphodiesterase inhibitors |
| 07/19/2006 | CN1805964A 1.3.4-triaza-phenalene and 1,3,4,6-tetraazaphenalene derivatives |
| 07/19/2006 | CN1805961A Perylenetetracarboxylic acid dibenzimidazole sulfoderivatives containing oxo-groups in the perylene core which form part of a para-quinoid system of bonds, lyotropic liquid crystal systems and anisotr |
| 07/19/2006 | CN1805960A 7-azaindoles and use thereof as therapeutic agents. |
| 07/19/2006 | CN1805959A Cycloalkanepyrrolopyridines as DP receptor antagonists |
| 07/19/2006 | CN1805958A Condensed N-heterocyclic compounds and their use as CRF receptor antagonists |
| 07/19/2006 | CN1803799A Camptothecin derivative used as anti-tumor agent and preparation method thereof |
| 07/19/2006 | CN1803797A Inhibitors of dipeptidyl peptidase IV |
| 07/19/2006 | CN1803793A Razole derivatives and application thereof |
| 07/19/2006 | CN1264841C Preparation of anti-cancer active material in camptothecinum cell and method for restraining cancer cell |
| 07/19/2006 | CN1264840C 8-methoxy-(1,2,4) triazolo (1,5-A) pyridine derivatives and their use as adenosine receptor ligands |
| 07/19/2006 | CN1264837C Antimicrobial quinolones, their compositions and uses |
| 07/19/2006 | CN1264828C Nitric ester and nitrate salts of specific drugs |
| 07/19/2006 | CN1264574C Oral preparations |
| 07/18/2006 | USRE39197 diaryl sulfides, substituted with cinnamides, such as (2,4-Dichlorophenyl)[2-(E-((6-hydroxyhexylamino)carbonyl)ethenyl)phenyl]sulfide, used for treating inflammatory and immune diseases in mammals |
| 07/18/2006 | US7078567 Forming c-n bonds; isomerization |
| 07/18/2006 | US7078523 Viricides; anticancer agents; immunology moderators |
| 07/18/2006 | US7078522 2-heterocycle-7-oxo-pyrido-[2,3-d]-pyrimidines or 2-oxo-7-heterocycle-1,6-naphthyridines; phosphodiesterase V inhibitors; erectile dysfunction; side effect reduction |
| 07/18/2006 | US7078410 4-substituted with a imidazo[1,2a]pyrid-3-yl or pyrazolo[2,3a]pyrid-3-yl ring |
| 07/18/2006 | US7078408 administering pyrimidinotriazole derivatives for improving motor impairment due to Parkinson's Disease |
| 07/18/2006 | US7078405 Psychological disorders; anxiolytic agents; dietetics; autoimmune diseases; antidepressants |
| 07/18/2006 | US7078209 Fused nitrogen heterocyclic compounds; treating fungal diseases |